EyePoint Pharmaceuticals Appoints George O. Elston as Chief Financial Officer and Head of Corporate Development

NEXT STORY
BioNTech SE Provides Update on Corporate Progress and Third Quarter 2019 Financial Results
PREV STORY
Amarin Corporation plc (NASDAQ:AMRN) Stock Trading Halted Today for Scheduled FDA Advisory Committee Review of sNDA Seeking New Indication for Vascepa® (Icosapent Ethyl) to Reduce the Risk of Major Adverse Cardiovascular Events Based on Landmark REDUCE-IT® Cardiovascular Outcomes Study
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Regional Leader: Highland Park Center & IVF Lab at Fertility Centers of Illinois

Highland Park Medical Director Dr. Edward L. Marut and Industry-Leading Physicians Dr. Brian R. ...

author_avatar
NASDAQ Market News

ARASENS trial with darolutamide in combination with docetaxel and androgen deprivation therapy meets primary endpoint of significantly increasing overall survival in patients with metastatic hormone-sensitive prostate cancer

author_avatar
NASDAQ Market News

Neon Therapeutics to Present at Morgan Stanley 16th Annual Global Healthcare Conference

CAMBRIDGE, Mass., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a ...

author_avatar
NASDAQ Market News